Indications and complications of intravenous devices for chemotherapy

被引:23
作者
Freytes, CO
机构
[1] Univ Texas, Hlth Sci Ctr, San Antonio, TX 78229 USA
[2] S Texas Vet Hlth Care Syst, San Antonio, TX 78229 USA
关键词
D O I
10.1097/00001622-200007000-00005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Vascular access devices (VADs) are frequently used in patients with cancer. Vascular access devices can be divided into external catheters and subcutaneous venous access ports. Each type of device has its advantages and disadvantages, but the indications and optimal use of specific VADs remain to be defined. There are multiple complications of VADs but, with the exception of catheter-related bloodstream infections and thrombosis, most complications are rare. The use of VADs impregnated with antibiotic reduces the rates of catheter colonization and catheter-related bloodstream infections as compared with the use of unimpregnated catheters for short-term use. Thrombosis remains a major complication of VADs, and prospective, controlled studies are needed to clearly define the risk factors, natural history, and optimal treatment of this complication. Curr Opin Oncol 2000, 12:303-307 (C) 2000 Lippincott Williams & Wilkins, Inc.
引用
收藏
页码:303 / 307
页数:5
相关论文
共 16 条
[1]   Diagnosis of catheter-related bacteraemia: a prospective comparison of the time to positivity of hub-blood versus peripheral-blood cultures [J].
Blot, F ;
Nitenberg, G ;
Chachaty, E ;
Raynard, B ;
Germann, N ;
Antoun, S ;
Laplanche, A ;
Brun-Buisson, C ;
Tancrede, C .
LANCET, 1999, 354 (9184) :1071-1077
[2]   Thrombotic complications of central venous catheters in cancer patients [J].
Bona, RD .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1999, 25 (02) :147-155
[3]   Totally implantable venous access ports systems for patients receiving chemotherapy for solid tissue malignancies: A randomized controlled clinical trial examining the safety, efficacy, costs, and impact on quality of life [J].
Bow, EJ ;
Kilpatrick, MG ;
Clinch, JJ .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (04) :1267-1273
[4]   CLASSICAL EXTERNAL INDWELLING CENTRAL VENOUS CATHETER VERSUS TOTALLY IMPLANTED VENOUS ACCESS SYSTEMS FOR CHEMOTHERAPY ADMINISTRATION - A RANDOMIZED TRIAL IN 100 PATIENTS WITH SOLID TUMORS [J].
CARDE, P ;
COSSETDELAIGUE, MF ;
LAPLANCHE, A ;
CHAREAU, I .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1989, 25 (06) :939-944
[5]   A comparison of two antimicrobial-impregnated central venous catheters [J].
Darouiche, RO ;
Raad, II ;
Heard, SO ;
Thornby, JI ;
Wenker, OC ;
Gabrielli, A ;
Berg, J ;
Khardori, N ;
Hanna, H ;
Hachem, R ;
Harris, RL ;
Mayhall, G .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (01) :1-8
[6]   Clinical utility of blood cultures drawn from indwelling central venous catheters in hospitalized patients with cancer [J].
DesJardin, JA ;
Falagas, ME ;
Ruthazer, R ;
Griffith, J ;
Wawrose, D ;
Schenkein, D ;
Miller, K ;
Snydman, DR .
ANNALS OF INTERNAL MEDICINE, 1999, 131 (09) :641-+
[7]  
Freytes CO, 1998, SUPPORT CARE CANCER, V6, P13
[8]   Serologic evidence of heparin sensitization in cancer patients receiving heparin flushes of venous access devices [J].
Mayo, DJ ;
Cullinane, AM ;
Merryman, PK ;
Horne, MK .
SUPPORTIVE CARE IN CANCER, 1999, 7 (06) :425-427
[9]   A COMPARISON OF PLACEMENT TECHNIQUES AND COMPLICATIONS OF EXTERNALIZED CATHETERS AND IMPLANTABLE PORT USE IN CHILDREN WITH CANCER [J].
MIRRO, J ;
RAO, BN ;
KUMAR, M ;
RAFFERTY, M ;
HANCOCK, M ;
AUSTIN, BA ;
FAIRCLOUGH, D ;
LOBE, TE .
JOURNAL OF PEDIATRIC SURGERY, 1990, 25 (01) :120-124
[10]   A PROSPECTIVE RANDOMIZED TRIAL COMPARING THE INFECTIOUS AND NONINFECTIOUS COMPLICATIONS OF AN EXTERNALIZED CATHETER VERSUS A SUBCUTANEOUSLY IMPLANTED DEVICE IN CANCER-PATIENTS [J].
MUELLER, BU ;
SKELTON, J ;
CALLENDER, DPE ;
MARSHALL, D ;
GRESS, J ;
LONGO, D ;
NORTON, J ;
RUBIN, M ;
VENZON, D ;
PIZZO, PA .
JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (12) :1943-1948